NanoTherapX is advancing next-generation nanomedicine for psoriasis, engineered to reduce inflammation, scaling, and recurrence. Our platform offers a safer, non-steroidal alternative with superior efficacy and long-lasting relief.
NanoTherapX Innovations develops plant-based nanotherapeutics for chronic inflammatory skin diseases. Built on deep translational research from IIT Bombay, their platform offers safe, steroid-free, and affordable alternatives to current treatments. They focus on precision topical nanomedicine, scalable manufacturing, and solutions aligned with India's vision for accessible, high-quality healthcare.
Bootstrapped to date; actively engaging with investors and grant agencies but not yet received.
One granted patent provides strong FTO in phytochemical-based nanotherapeutic formulations.
Recognized nationally for excellence in translational nanomedicine and healthcare innovation through multiple prestigious awards.
The core team, affiliated with IIT Bombay, includes scientists and advisors experienced in cutting-edge nanomedicine, clinical translation, product development, and regulatory pathways.
CTO
Chief Scientific Advisor
Chief Scientific Advisor
Chief Financial Advisor
